AR036755A1 - Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel - Google Patents

Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel

Info

Publication number
AR036755A1
AR036755A1 ARP020103777A ARP020103777A AR036755A1 AR 036755 A1 AR036755 A1 AR 036755A1 AR P020103777 A ARP020103777 A AR P020103777A AR P020103777 A ARP020103777 A AR P020103777A AR 036755 A1 AR036755 A1 AR 036755A1
Authority
AR
Argentina
Prior art keywords
composition
skin
transparent gel
administration
sodium diclofenac
Prior art date
Application number
ARP020103777A
Other languages
English (en)
Inventor
Francisco Jose Evaristo Stefano
Original Assignee
Thalas Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thalas Group Inc filed Critical Thalas Group Inc
Priority to ARP020103777A priority Critical patent/AR036755A1/es
Priority to AU2003269266A priority patent/AU2003269266A1/en
Priority to PCT/GB2003/004398 priority patent/WO2004030665A1/en
Publication of AR036755A1 publication Critical patent/AR036755A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición en forma de gel transparente, para la administración tópica, local o sistémica de diclofenac a través de la piel que comprende diclofenac sódico en una concentración mayor o igual al 5% en peso y una mezcla de alcohol oleílico/alcohol isopropílico en una relación comprendida entre 0,025 y 0,05. Dicha composición comprende además excipientes farmacéuticamente aceptables. Un procedimiento para la preparación de dicha composición.
ARP020103777A 2002-10-07 2002-10-07 Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel AR036755A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ARP020103777A AR036755A1 (es) 2002-10-07 2002-10-07 Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel
AU2003269266A AU2003269266A1 (en) 2002-10-07 2003-10-07 Transparent gel composition, for the administration of diclofenac sodium through the skin
PCT/GB2003/004398 WO2004030665A1 (en) 2002-10-07 2003-10-07 Transparent gel composition, for the administration of diclofenac sodium through the skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP020103777A AR036755A1 (es) 2002-10-07 2002-10-07 Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel

Publications (1)

Publication Number Publication Date
AR036755A1 true AR036755A1 (es) 2004-09-29

Family

ID=32046253

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103777A AR036755A1 (es) 2002-10-07 2002-10-07 Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel

Country Status (3)

Country Link
AR (1) AR036755A1 (es)
AU (1) AU2003269266A1 (es)
WO (1) WO2004030665A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
WO2010008600A1 (en) * 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
KR20120026050A (ko) * 2009-04-08 2012-03-16 카딜라 핼쓰캐어 리미티드 디클로페낙의 안정한 약학적 조성물
EA201391043A1 (ru) * 2011-02-17 2014-03-31 Сентисс Фарма Прайвет Лимитед Способ и композиция для замедления сорбции консервантов пластиками
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
AU2015313842A1 (en) 2014-09-10 2017-03-30 Novartis Consumer Health S.A. Topical diclofenac sodium compositions
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof
EP4342449A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic single phase gel compositions for topical delivery of diclofenac
EP4342450A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic topical diclofenac formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788794A4 (en) * 1994-08-09 2000-06-28 Tsumura & Co COMPOSITION FOR PREPARATION FOR EXTERNAL USE
EP0879597A4 (en) * 1996-02-07 2001-01-31 Tsumura & Co TRANSPARENT AQUEOUS SOLUTION OF DICLOFENAC SODIUM, MEDICINAL COMPOSITIONS, AND USES

Also Published As

Publication number Publication date
AU2003269266A1 (en) 2004-04-23
WO2004030665A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
AR059324A2 (es) Una forma solida de dosificacion oral
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
AR033808A1 (es) Una composicion topica de anestesia local y los parches y los envases que la contienen
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
AR037260A1 (es) Formulaciones de proteinas de liberacion sostenida acuosas
BR0307540A (pt) Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo
DOP2001000241A (es) Formulaciones de liberación sostenida para secretagogos de hormona del crecimiento
AR055552A1 (es) Preparacion topica refrescante para parches y metodos para utilizar la misma
HRP20030046B1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
AR012376A1 (es) Formulacion de gel para la aplicacion topica
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
AR036755A1 (es) Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel
ES2080844T3 (es) Composiciones administradas topicamente basadas en acido hialuronico de alto peso molecular para el tratamiento de las inflamaciones de la cavidad oral y para la higiene y el tratamiento cosmetico de la cavidad oral.
AR047191A1 (es) Metodos de tratamiento de fibrosis hepatica
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
ES2160680T3 (es) Utilizacion de un antagonista de sustancia p en una composicion farmaceutica.
AR017222A1 (es) Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
AR064263A1 (es) Composiciones farmaceuticas que comprenden un compuesto bisfosfato
BR0116972A (pt) Métodos e dispositivos para administração de substâncias na camada intradérmica da pele para absorção sistêmica

Legal Events

Date Code Title Description
FB Suspension of granting procedure